Below are the most recent publications written about "Viral Load" by people in Profiles.
-
Moriarty RV, Harwood OE, Johnson EP, Gardner W, Valencia CC, Conchas A, Immonen TT, Reynolds MR, Keele BF, O'Connor SL. CD8?+ cells suppress SIV replication without the development of mutations within MHC class-I-restricted epitopes during post-treatment control. J Virol. 2026 Jul 21; 100(7):e0004126.
-
Nguyen TVH, Vu ND, Nguyen VD, Than TT, Dang TN, Nguyen HT, Tran TCG, Nguyen HT, Nguyen PA, Cho KH, Hong SK, Ambagala A, Kim YH, Le VP. Pathobiological characterization and estimation of the basic reproduction number of a recombinant african swine fever virus in contact-exposed pigs in Vietnam. Vet Microbiol. 2026 May; 316:110961.
-
Bui HTM, Goldberg RJ, Dao ATM, Nguyen HL, Maher L, Vu D, Nguyen H, Nguyen HT, Le GM. Homosexuality-related stigma and sustained viral suppression among men who have sex with men living with HIV in Vietnam. AIDS Care. 2026 Aug; 38(8):1745-1758.
-
Salomon-Escoto K, Stutsky M, Reed G, Hinestroza Jordan MY, Kay J, Wessolossky M. Greater HIV Viral Load Suppression in Patients Using an Integrated Health System Specialty Pharmacy. J Pharm Pract. 2026 Jun; 39(3):204-210.
-
Chen AP, Cheng CY, Lee CY, Liu WD, Ho MW, Chen WY, Chen TC, Liou BH, Chuang HC, Tsai MS, Cheng MY, Tang HJ, Tsai HC, Lee MH, Chen KH, Lee CH, Liu CW, Lee YC, Yang CH, Yang CJ. Disproportionate presentation of Mpox among people with HIV: A multicenter retrospective cohort study in Taiwan. J Microbiol Immunol Infect. 2025 Dec; 58(6):663-669.
-
Herbert C, Antar AAR, Broach J, Wright C, Stamegna P, Luzuriaga K, Hafer N, McManus DD, Manabe YC, Soni A. Relationship Between Acute SARS-CoV-2 Viral Clearance and Long COVID-19 (Long COVID) Symptoms: A Cohort Study. Clin Infect Dis. 2025 02 05; 80(1):82-90.
-
Phan T, Ribeiro RM, Edelstein GE, Boucau J, Uddin R, Marino C, Liew MY, Barry M, Choudhary MC, Tien D, Su K, Reynolds Z, Li Y, Sagar S, Vyas TD, Kawano Y, Sparks JA, Hammond SP, Wallace Z, Vyas JM, Li JZ, Siedner MJ, Barczak AK, Lemieux JE, Perelson AS. Modeling suggests SARS-CoV-2 rebound after nirmatrelvir-ritonavir treatment is driven by target cell preservation coupled with incomplete viral clearance. J Virol. 2025 03 18; 99(3):e0162324.
-
Ngo HHT, Pham TPT, Hoang HTT, Bui DH, Phan HTT, Nguyen QC, Duong TC, Bui HT, Nguyen HTT, Le MQT, Dang AD, McFarland W, Truong HM, Pham TH. Detection of Antiretroviral Drug-Resistant Mutations and HIV-1 Subtypes in Circulation Among Men Who Have Sex With Men, SEM Females, and Female Sex Workers: Results of Vietnam's HIV Sentinel Surveillance Plus System, 2018-2020. J Acquir Immune Defic Syndr. 2025 01 01; 98(1):29-36.
-
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Clifford Lane H, Beigel J, Dodd LE. SARS-CoV-2 RNA and Nucleocapsid Antigen Are Blood Biomarkers Associated With Severe Disease Outcomes That Improve in Response to Remdesivir. J Infect Dis. 2024 Sep 23; 230(3):624-634.
-
Herbert C, Manabe YC, Filippaios A, Lin H, Wang B, Achenbach C, Kheterpal V, Hartin P, Suvarna T, Harman E, Stamegna P, Rao LV, Hafer N, Broach J, Luzuriaga K, Fitzgerald KA, McManus DD, Soni A. Differential Viral Dynamics by Sex and Body Mass Index During Acute SARS-CoV-2 Infection: Results From a Longitudinal Cohort Study. Clin Infect Dis. 2024 05 15; 78(5):1185-1193.